Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more
here
.
About Us
About hVIVO
Leadership Team
Our Companies
Key Stats
History
Services
Challenge Trials
RSV
Influenza
COVID-19
HRV
Malaria
Asthma & COPD
Laboratory Services
Assay Development
Field Trial Bio-logistics
Cell Based Assays
Molecular Services
Compound Efficacy & VRM
Biomarker Analysis
Phase II-III Clinical Trials
Vaccine Phase II-III Trials
Articles & Research
News & Media
Regulatory News
Media Coverage
Media Press Kit
Video Library
Events
Investors
New
Investors
Regulatory News & Email Alerts
Results Centre
Share Price Information
Events & Presentations
Environmental, Social & Governance
AIM Rule 26
Advisors
Documents
Corporate Governance
Volunteers
Careers
Contact Us
Contact Us
Articles & Research
from hVIVO
Article Types Filter
Article Types Filter
Blog
Article
Presentation
Scientific Paper
Factsheet
Case Study
Article Count
1 - 10 of 36 posts
Article
22 Mar 2023
Utilising Human Challenge Trials as a tool in expedited review programs for infectious diseases
Featured on pages 18-19
View Link
Blog
20 Mar 2023
Advantages to Centralising Laboratory Services at hVIVO
Clinical field studies are a critical part of the drug development and approval process. They are conducted to evaluate the safety, immunogenicity, and efficacy of a new drug. These studies...
Read more
Blog
07 Mar 2023
EMA’s updated guideline to include broader coverage on Human Challenge Trials
View Link
Blog
20 Feb 2023
Advantages of Human Challenge Studies (Part 1)
Human challenge studies or controlled human infection model (CHIM) studies are Phase Ib or Phase IIa clinical trials, in which study participants, i.e. healthy volunteers, are deliberately exposed to infectious...
Read more
Article
07 Feb 2023
Accelerated regulatory pathways: Vaccines for tropical diseases
View Link
Article
24 Nov 2022
Human Clinical Trials: A Tool in the Fight Against Infectious Diseases
In the wake of the COVID-19 pandemic, research into infectious diseases remains an integral and growing avenue of clinical research. What benefits can Human Challenge Trials have for clinicians exploring...
Read more
Presentation
03 Oct 2022
RSV Vaccines/Prophylactics: Key learnings from the RSV challenge model and efficacy of vaccines
Challenge studies can be a powerful tool in the development of both therapeutic agents and vaccines. However, key decisions made in the study design process can have a profound impact...
Read more
Presentation
03 Oct 2022
Initial characteristics of respiratory viruses in symptomatic subjects during the pandemic, a cohort study
During the most intense waves of the recent pandemic, we have witnessed a clear and almost complete wipe-out of many respiratory viruses routinely circulating in the community over the north-hemisphere...
Read more
Presentation
03 Oct 2022
Immunomodulators and treatment of disease in the influenza human challenge model
Human challenge studies using wild-type viruses replicate what is seen in the field in the same populations, and as such they have been used to aid vaccine and drug development...
Read more
Blog
24 Aug 2022
Human Challenge Studies: Their Conduct and Safety Aspects
If there would be a survey of 100 clinical research professionals either from CRO or from Pharma/Biotech industry to explain what a human challenge study is, the most common answer...
Read more
Article Pagination
1
2
3
4
Articles Per Page
Articles Per Page
8
10
16
24
32
angle-down
meetup
chevron-down